JPH0362447B2 - - Google Patents
Info
- Publication number
- JPH0362447B2 JPH0362447B2 JP57158057A JP15805782A JPH0362447B2 JP H0362447 B2 JPH0362447 B2 JP H0362447B2 JP 57158057 A JP57158057 A JP 57158057A JP 15805782 A JP15805782 A JP 15805782A JP H0362447 B2 JPH0362447 B2 JP H0362447B2
- Authority
- JP
- Japan
- Prior art keywords
- molecular weight
- glycerin
- cellulose ester
- hollow fibers
- permeability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012510 hollow fiber Substances 0.000 claims description 37
- 229920002678 cellulose Polymers 0.000 claims description 33
- 230000035699 permeability Effects 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 150000005846 sugar alcohols Polymers 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 10
- 238000002074 melt spinning Methods 0.000 claims description 10
- 229920000570 polyether Polymers 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 7
- 102000004506 Blood Proteins Human genes 0.000 claims description 4
- 108010017384 Blood Proteins Proteins 0.000 claims description 4
- 230000005764 inhibitory process Effects 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 3
- 229920001202 Inulin Polymers 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 150000002314 glycerols Chemical class 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 238000000502 dialysis Methods 0.000 description 15
- 239000012528 membrane Substances 0.000 description 13
- 238000005194 fractionation Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000002202 Polyethylene glycol Substances 0.000 description 11
- 229920001223 polyethylene glycol Polymers 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 229920001747 Cellulose diacetate Polymers 0.000 description 6
- 239000004721 Polyphenylene oxide Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000009987 spinning Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000010035 extrusion spinning Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Artificial Filaments (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15805782A JPS5949806A (ja) | 1982-09-13 | 1982-09-13 | セルロースエステル系中空糸状分離膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15805782A JPS5949806A (ja) | 1982-09-13 | 1982-09-13 | セルロースエステル系中空糸状分離膜 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5949806A JPS5949806A (ja) | 1984-03-22 |
| JPH0362447B2 true JPH0362447B2 (fr) | 1991-09-26 |
Family
ID=15663348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15805782A Granted JPS5949806A (ja) | 1982-09-13 | 1982-09-13 | セルロースエステル系中空糸状分離膜 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5949806A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE446505B (sv) * | 1982-11-16 | 1986-09-22 | Gambro Dialysatoren | Membran samt sett att framstella detta |
| JPS605202A (ja) * | 1983-06-21 | 1985-01-11 | Teijin Ltd | 多孔性セルロ−スエステル系中空繊維およびその製造方法 |
| EP0697242A4 (fr) * | 1994-03-08 | 1997-10-08 | Teijin Ltd | Membrane de purification du sang a base de fibres creuses et son procede de production |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5442420A (en) * | 1977-07-05 | 1979-04-04 | Cordis Dow Corp | Improved cellulose acetate hollow fiber and production thereof |
| JPS6352526A (ja) * | 1986-08-22 | 1988-03-05 | Nec Corp | 自動車電話システムの一斉放送方式 |
-
1982
- 1982-09-13 JP JP15805782A patent/JPS5949806A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5442420A (en) * | 1977-07-05 | 1979-04-04 | Cordis Dow Corp | Improved cellulose acetate hollow fiber and production thereof |
| JPS6352526A (ja) * | 1986-08-22 | 1988-03-05 | Nec Corp | 自動車電話システムの一斉放送方式 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5949806A (ja) | 1984-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2782583B2 (ja) | 非対称微孔性中空繊維 | |
| KR100432463B1 (ko) | 폴리술폰 중공사 반투막 | |
| EP1110563B1 (fr) | Dialyseurs pour le traitement du sang et leurs procédés de fabrication | |
| KR102230435B1 (ko) | 다공질막, 다공질막을 내장하는 혈액 정화용 모듈 및 다공질막의 제조 방법 | |
| CA2202969C (fr) | Membrane de fibres creuses selectivement permeable et procede de fabrication | |
| JPH10108907A (ja) | 血液浄化膜、その製造方法及び血液浄化用モジュール | |
| EP0012630B1 (fr) | Procédé pour la fabrication d'une membrane sélectivement perméable du type acétate de cellulose, membrane sélectivement perméable ainsi fabriquée et utilisation d'une telle membrane dans un rein artificiel | |
| AU672856B2 (en) | High flux hollow fiber membrane | |
| US5849189A (en) | Hollow fiber blood purifying membrane and process for its production | |
| JPS605202A (ja) | 多孔性セルロ−スエステル系中空繊維およびその製造方法 | |
| JPH0362447B2 (fr) | ||
| JP2003290638A (ja) | ポリスルホン系半透膜およびそれを用いた人工腎臓 | |
| JPH0970431A (ja) | ポリスルホン系中空糸型人工腎臓の製造方法および人工腎臓 | |
| JPH0566169B2 (fr) | ||
| JP2011020071A (ja) | ポリスルホン系中空糸膜の製造方法 | |
| JPS6352526B2 (fr) | ||
| JP2003126664A (ja) | 半透膜の製造方法およびその半透膜を用いた透析器 | |
| JP2710711B2 (ja) | セルロースジアセテート中空糸 | |
| JP2710710B2 (ja) | 流体分離器 | |
| JPS61274706A (ja) | セルロ−ス系中空糸，その製造方法及び流体分離器 | |
| JP2001029762A (ja) | セルロース系血液浄化用膜 | |
| JP2001029758A (ja) | 再生セルロース中空糸膜の製造方法 |